IDYA
Price
$36.17
Change
-$0.86 (-2.32%)
Updated
Jan 15, 11:38 AM (EDT)
Capitalization
3.25B
75 days until earnings call
Intraday BUY SELL Signals
IMNM
Price
$20.74
Change
-$0.02 (-0.10%)
Updated
Jan 15, 11:39 AM (EDT)
Capitalization
2.29B
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IDYA vs IMNM

Header iconIDYA vs IMNM Comparison
Open Charts IDYA vs IMNMBanner chart's image
IDEAYA Biosciences
Price$36.17
Change-$0.86 (-2.32%)
Volume$200
Capitalization3.25B
Immunome
Price$20.74
Change-$0.02 (-0.10%)
Volume$1.27K
Capitalization2.29B
IDYA vs IMNM Comparison Chart in %
IDYA
Daily Signal:
Gain/Loss:
IMNM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IDYA vs. IMNM commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and IMNM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (IDYA: $37.03 vs. IMNM: $20.76)
Brand notoriety: IDYA and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 164% vs. IMNM: 124%
Market capitalization -- IDYA: $3.25B vs. IMNM: $2.29B
IDYA [@Biotechnology] is valued at $3.25B. IMNM’s [@Biotechnology] market capitalization is $2.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 1 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 1 green, 4 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 3 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • IMNM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than IMNM.

Price Growth

IDYA (@Biotechnology) experienced а -2.19% price change this week, while IMNM (@Biotechnology) price change was +3.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

IDYA is expected to report earnings on Mar 31, 2026.

IMNM is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($3.25B) has a higher market cap than IMNM($2.29B). IDYA YTD gains are higher at: 7.116 vs. IMNM (-3.352). IDYA has higher annual earnings (EBITDA): -204.84M vs. IMNM (-231.45M). IDYA has more cash in the bank: 787M vs. IMNM (273M). IMNM has less debt than IDYA: IMNM (4.01M) vs IDYA (27.2M). IDYA has higher revenues than IMNM: IDYA (215M) vs IMNM (9.68M).
IDYAIMNMIDYA / IMNM
Capitalization3.25B2.29B142%
EBITDA-204.84M-231.45M89%
Gain YTD7.116-3.352-212%
P/E RatioN/AN/A-
Revenue215M9.68M2,221%
Total Cash787M273M288%
Total Debt27.2M4.01M678%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
57
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAIMNM
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signal:
Gain/Loss:
IMNM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFGIX15.620.08
+0.51%
Seafarer Overseas Gr and Income Investor
OCIEX16.130.05
+0.31%
Optimum International C
TRMSX22.88-0.03
-0.13%
T. Rowe Price Mid-Cap Index I
PFGEX28.17-0.28
-0.98%
Parnassus Growth Equity Investor
TWUIX101.21-1.22
-1.19%
American Century Ultra® I

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+5.53%
NUVL - IDYA
59%
Loosely correlated
+6.59%
XNCR - IDYA
58%
Loosely correlated
+3.66%
XENE - IDYA
57%
Loosely correlated
+3.02%
DYN - IDYA
55%
Loosely correlated
+2.41%
VIR - IDYA
55%
Loosely correlated
+8.08%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KURA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+3.08%
KURA - IMNM
53%
Loosely correlated
+1.63%
VYGR - IMNM
52%
Loosely correlated
+2.74%
IDYA - IMNM
52%
Loosely correlated
+5.53%
NRIX - IMNM
52%
Loosely correlated
+0.58%
RLAY - IMNM
51%
Loosely correlated
+1.64%
More